Janux Therapeutics, Inc. (JANX)
13.94
-0.13
(-0.92%)
USD |
NASDAQ |
Dec 30, 10:58
Janux Therapeutics EPS Diluted (Quarterly): -0.392 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Stoke Therapeutics, Inc. | -0.6543 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MannKind Corp. | 0.0256 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.31M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 34.31M |
| Enterprise Value | -120.05M |
| Gross Profit Margin (Quarterly) | 94.99% |
| Profit Margin (Quarterly) | -243.1% |
| Earnings Yield | -12.02% |
| Normalized Earnings Yield | -12.02 |